Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. - Wikidata - wikimedia - TriplyDB

Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.

Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.

http://www.wikidata.org/entity/Q44477055

about

PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases.Metabolic Functions of the Lung, Disorders and Associated Pathologies Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.Pulmonary macrophage transplantation therapy Regulation of macrophage development and function in peripheral tissues Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis.The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects.The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarization PPARgamma: a novel molecular target in lung disease.The Role of PPARs in Lung Fibrosis.PPARs in alveolar macrophage biology.Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.Role of PPARγ in COX-2 activation in mycobacterial pulmonary inflammation.Whole lung lavage for pulmonary alveolar proteinosis after surgery for spontaneous pneumothorax.Alveolar macrophage cathelicidin deficiency in severe sarcoidosis.Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.Rare lung disease II: pulmonary alveolar proteinosis.Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF.Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function.Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis.GM-CSF pathway correction in pulmonary alveolar proteinosis.Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.Understanding macrophage diversity at the ontogenic and transcriptomic levels.The development and function of lung-resident macrophages and dendritic cells.The Role of PPAR Gamma in Systemic Sclerosis.Cystic Fibrosis Lung Immunity: The Role of the Macrophage Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages.Targeting cholesterol homeostasis in lung diseases.Targeted PPAR{gamma} deficiency in alveolar macrophages disrupts surfactant catabolism Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes.Human lung fibroblasts produce proresolving peroxisome proliferator-activated receptor-γ ligands in a cyclooxygenase-2-dependent manner.Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis.A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP).Mesenchymal Stem Cell Soluble Mediators and Cystic Fibrosis.New mutations in the SLC7A7 gene of two chinese sisters with lysinuric protein intolerance.

P2860

Q23911525-CF8979DC-D7C4-4C88-8E3E-E7FF4E41F61B Q24323199-A25BF07E-99AB-4775-A89E-1F2C1CB262DD Q24814517-5897C94D-01CC-4EDB-8494-7C193F3AB641 Q28072037-D7FD7277-AF59-447F-8686-7BE30C19DAAC Q28393487-5321B76F-9165-4FC7-98C4-FB004B3B2D6D Q33988125-67F26E44-4657-48BA-9ED5-3D7C6D1C418A Q34539736-72635948-9711-45F3-9528-F44037797338 Q34674559-59C41DA5-CE0D-41F4-98CD-E68334B4FC51 Q34992980-66A440FF-96E2-43CE-B4A7-620331729F18 Q35503543-288990C3-87DC-478D-9527-9E709B65E2A0 Q35600280-D03E748C-C884-4B76-8362-EEBA076F604B Q35805954-5E15F8AC-09A3-4ADC-B21A-ABEE2B72D3EF Q35925362-F446F110-922B-4B3E-A431-895DE9927F1D Q36121727-878D57C2-4545-4E12-8F87-397BE60908D2 Q36204781-2B7E85E5-77F4-4D1C-BED9-F7B43147587F Q36230193-4B5DA71D-3925-4F15-B571-6E22394338DF Q36299828-54E537DF-1CF1-4583-BEBF-5743CE09A392 Q36321921-1FD22129-2CFF-44E8-AC66-CE8C23685801 Q37072048-C221E2E8-CCA5-47FE-8367-59A51E6F5F78 Q37181748-4C647542-1B68-489A-A7AF-00C7CCD0E135 Q37194936-A190331D-0EEC-4A96-938F-16F2B64AD2F4 Q37246501-9C10A89D-A941-4309-A6CA-2EFF4F604FF4 Q37698322-244B54DD-9F70-46EB-80CC-B88276E81F31 Q37778844-9CE3FF38-4CEC-4568-A0B8-919FEF775E3C Q37847083-E7B76140-56DC-4483-A684-8408C2131931 Q38260569-103BE084-FA1B-4EA2-AD35-00727E51F6C4 Q38293022-06B3C470-2D7D-4DF7-A0BE-5CCA8D32098A Q38524619-38A10177-A4CE-466C-B475-240DA3359E1A Q38874414-A9FF3D79-DFBA-4FFA-8EA5-B519FC3570D4 Q39990710-D79EEBF4-5A30-4B30-9E82-93965C8DAB07 Q41117124-8BD82460-9CDC-4901-B9DE-3BC03414E3E0 Q41581562-669870A2-3753-4511-AD10-30546D4D70EF Q41767102-2161F5F6-F783-4AAF-8FF7-0CBD4CEA7902 Q42176757-E2A1A28E-0ACB-43F5-86E5-D715DA72A2EA Q42784201-76F8998D-91E4-4BAE-9283-617CC873B958 Q43058950-BA9FA2B6-DD70-4700-BB1C-F402BF48010C Q44598265-F7ED83D0-5358-4ADB-AC5D-E4FF471037EC Q46358328-036C904B-2857-4A29-9EB1-C635D92573E6 Q47132756-A392DA3A-607D-47A6-B675-FF3EB5A67D76 Q47617629-BC79EE48-A07D-4C76-A1E4-F3D168E359CD

P2860

Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.

http://www.wikidata.org/entity/Q44477055

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Peroxisome proliferator-activa ...... nts with alveolar proteinosis.

@en

Peroxisome proliferator-activa ...... nts with alveolar proteinosis.

@nl

type

label

Peroxisome proliferator-activa ...... nts with alveolar proteinosis.

@en

Peroxisome proliferator-activa ...... nts with alveolar proteinosis.

@nl

prefLabel

Peroxisome proliferator-activa ...... nts with alveolar proteinosis.

@en

Peroxisome proliferator-activa ...... nts with alveolar proteinosis.

@nl

P1433

Q44477055-332C53CC-A244-44C5-BDF3-ADE9EDAC15AF

P1476

Q44477055-4E2C7564-FDF1-47AA-B451-3B6E49BB4CE9

P2093

Q44477055-2E10D30D-2EBF-47AC-810C-2D909E87002C

Q44477055-77E2C836-E2F4-49A8-AFE0-D6F5EE869329

Q44477055-7BD2245F-06A1-4308-9069-9643976D257D

Q44477055-80EEDCC7-AD73-4047-9AF9-A958C269ED1A

Q44477055-946D36CF-85BE-4CA3-92AD-350B0B8F3E86

Q44477055-9BC039E7-09A7-4334-8BF7-099314D3A743

Q44477055-B7FA1D6D-A5D1-41AF-B766-6A062BF97519

Q44477055-E4AA123C-D0BB-4B36-AEC0-E41A7CF9523D

P2860

Q44477055-0594126C-37A7-4D12-BB82-F7FCDDAB1875

Q44477055-09D8FEFE-2B4A-46EF-B714-6398E379AFF4

Q44477055-10A46DE8-3E18-4382-A682-1F85720C9856

Q44477055-13DE3060-9396-4226-9921-3C78DBCBE801

Q44477055-170904D7-8555-4CED-B36C-15017B0CDBC5

Q44477055-1EAE8601-B507-446F-9636-FAB466BBC277

Q44477055-2F64AC96-FB29-4DBC-8776-A82A41068EC0

Q44477055-3982E4E9-BAFC-4514-A78C-D58DE28D5766

Q44477055-39F747CC-6111-480A-B5D2-036DFF608957

Q44477055-531CD2EF-C01A-4CA3-8380-9D8F57659308

P304

Q44477055-D61D9175-7EA2-48A1-9AA5-373C392E954B

P31

Q44477055-3EC1B2E3-0BC0-4F68-A486-921EAF622FFD

P356

Q44477055-C5DB150B-AF35-469E-96F9-157B74201BED

P433

Q44477055-EF455134-F508-41A3-ACFF-65B932895ED0

P478

Q44477055-62CEE732-2E59-4704-B813-968842D8B3F2

P577

Q44477055-FDAD97D7-1718-47D7-AFFB-A4B49DD0F024

P698

Q44477055-D94D1421-D649-497F-B925-47FAF248D704

P921

Q44477055-8C910052-9DF2-44A3-B876-C8852939183E

Q44477055-FA64C471-C103-4E9C-83B5-1B82FEB95708

P356

RCMB.2003-0148OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Peroxisome proliferator-activa ...... nts with alveolar proteinosis.

@en

P2093

Anagha Malur

http://www.w3.org/2001/XMLSchema#string

Baisakhi Raychaudhuri

http://www.w3.org/2001/XMLSchema#string

Barbara P Barna

http://www.w3.org/2001/XMLSchema#string

Carol F Farver

http://www.w3.org/2001/XMLSchema#string

Mani S Kavuru

http://www.w3.org/2001/XMLSchema#string

Mary Jane Thomassen

http://www.w3.org/2001/XMLSchema#string

Susamma Abraham

http://www.w3.org/2001/XMLSchema#string

Tracey L Bonfield

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

The mechanisms of action of PPARs

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

Pulmonary surfactant in health and human lung diseases: state of the art.

Pulmonary alveolar proteinosis: progress in the first 44 years.

P304

677-682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2003-0148OC

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12805087

http://www.w3.org/2001/XMLSchema#string

P921